Some GLP-1 patients are begging to stay on the drugs just a little bit longer, presenting an ethical dilemma for doctors.
By Don Thompson for KFF Health News. Broadcast version by Suzanne Potter for California News Service reporting for the KFF Health News-Public News Service Collaboration Calif. — Many low-income ...
As obesity rates continue to climb globally, these injectable medications have gained popularity among individuals seeking a more structured medical approach to weight management. However, ...